Cargando…
Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
Patients with acute coronary syndrome (ACS) require long-term antithrombotic intervention to reduce the risk of further ischemic events; dual antiplatelet therapy with a P2Y(12) inhibitor and acetylsalicylic acid (ASA) is the current standard of care. However, pivotal clinical trials report that pat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555775/ https://www.ncbi.nlm.nih.gov/pubmed/30972665 http://dx.doi.org/10.1007/s40261-019-00769-6 |